Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

CureVac, BioNTech, Valeo Pharma: Where is there still potential?

The race for vaccines against Covid-19 is fierce. Every day there are new water level reports - from setbacks to breakthroughs, everything is there. The Tübingen-based Company CureVac ( NASDAQ: CVAC ) recently started its phase study IIa in Peru and Panama. Around 700 people...
Nico Popp | October 16, 2020 |

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...
Richard (Rick) Mills | April 24, 2020 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

June 30th 2020, Crypto Chartbook: Back to the future

Back to the future When reading fiction of time travel into the past or watching movies about time machines one theme dominates. The people who travel back in time worry immensely about how their behavior alters history. They fear about all the consequences of what they d...
Korbinian Koller | June 30, 2020 |

BioHarvest Sciences – Growing Exponentially

BioHarvest Sciences (CSNX: BHSC) is a rising star in the food, nutraceutical and cannabis industries. Through its intellectual property, it has developed a shortcut that could lead to cost savings and larger gross margins for its partners and future clients as well as a ...
Dr. Kal Kotecha | October 2, 2020 |

The Plant-Based / Psychedelics Hybrid Co. “Positioned For Growth”

(Click image to play video) M eet the Company and its CEO that’s positioning itself to be the premier cannabis commercialization extractor and manufacturing partner for functional psychedelic mushroom companies. Based on extensive extractio...
Dave Jackson | November 2, 2020 |

Simple, Uncomplicated: Find Out What Natural Beauty is All About

(Click image to play video) 2020 has been a whirlwind year for Marianna Naturals Corp. ( MRNN , Forum ). Founded in April of 2020 by both Co-Founder & Chairwoman Heather Marianna and Co-Founder, President & CEO Joel DeBellefeuille as the company is ...
Dave Jackson | February 4, 2021 |

“Empowering” a New Revolution in Mind, Body and Health Care

When Stockhouse first met up with Empower Clinics Inc . ( CSE.CBDT , OTCQB: EPWCF , Forum ) back in February 2020 , the company was pioneering new technologies in the still-emerging medical cannabis and CBD markets. Fast-forward to today and Empower Clinics has pi...
Dave Jackson | December 15, 2021 |